Evotec SE in 1 story
The narratives EVT.DE currently appears in, with its side and exposure in each.
Bull side
0 storiesNo bull-side stories for EVT.DE yet.
Bear side
1 story- China Becomes Pharma's Global R&D Engine
EVT.DE in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
Evotec's Western discovery and development services could face pricing pressure as sponsors gain access to lower-cost Chinese research capabilities and licensable clinical-stage assets.